{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:26:55Z","timestamp":1779935215517,"version":"3.53.1"},"reference-count":39,"publisher":"Baishideng Publishing Group Inc.","issue":"42","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2018,11,14]]},"DOI":"10.3748\/wjg.v24.i42.4721","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T07:32:09Z","timestamp":1542094329000},"page":"4721-4727","source":"Crossref","is-referenced-by-count":30,"title":["Increased susceptibility of aging gastric mucosa to injury and delayed healing: Clinical implications"],"prefix":"10.3748","volume":"24","author":[{"given":"Andrzej S","family":"Tarnawski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988; 2: 349-360"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Antithrombotic Trialists\u2019 Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86","DOI":"10.1136\/bmj.324.7329.71"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Hung J, Medical Issues Committee of the National Heart Foundation of Australia. Aspirin for cardiovascular disease prevention. Med J Aust 2003; 179: 147-152","DOI":"10.5694\/j.1326-5377.2003.tb05474.x"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231: 232-235","DOI":"10.1038\/newbio231232a0"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. Cyclooxygenase in biology and disease. FASEB J 1998; 12: 1063-1073","DOI":"10.1096\/fasebj.12.12.1063"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-0645rev"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Halter F, Tarnawski AS, Schmassmann A, Peskar BM. Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut 2001; 49: 443-453","DOI":"10.1136\/gut.49.3.443"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052717"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.10738"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011233432103"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, Rawlins M, Vessey M, Wainwright P. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-830","DOI":"10.1136\/bmj.310.6983.827"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000; 321: 1183-1187","DOI":"10.1136\/bmj.321.7270.1183"},{"key":"ref13","unstructured":"Fries JF, Bruce B. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 2003; 30: 2226-2233"},{"key":"ref14","unstructured":"Sibilia J, Ravaud P, Marck G. [Digestive and hemorrhage complications of low-dose aspirin]. Presse Med 2003; 32: S17-S28"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2005.10.006"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ph3072225"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.12.022"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i11.1673"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Cryer B, Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999; 117: 17-25","DOI":"10.1016\/S0016-5085(99)70545-7"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Garc\u00eda Rodr\u00edguez LA, Hern\u00e1ndez-D\u00edaz S. Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol 2004; 159: 23-31","DOI":"10.1093\/aje\/kwh005"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01517.x"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03928.x"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103293441304"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.08.037"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00127.2013"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2018.05.003"},{"key":"ref27","unstructured":"Ahluwalia A, Jones MK, Szabo S, Tarnawski AS. Aging impairs transcriptional regulation of vascular endothelial growth factor in human microvascular endothelial cells: implications for angiogenesis and cell survival. J Physiol Pharmacol 2014; 65: 209-215"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00382.2013"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i16.4467"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2004.06.015"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00334.2016"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2017.08.006"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i34.3908"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30770-5"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-4-22"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Tarnawski AS, Caves TC. Aspirin in the XXI century: its major clinical impact, novel mechanisms of action, and new safer formulations. Gastroenterology 2004; 127: 341-343","DOI":"10.1053\/j.gastro.2004.05.037"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.436"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61720-0"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.01.017"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v24\/i42\/4721.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T20:59:08Z","timestamp":1572641948000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v24\/i42\/4721.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":39,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2018,11,14]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v24.i42.4721","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11,14]]}}}